Market Research Report
Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2020 - 2027
|Published by||Grand View Research, Inc.||Product code||963079|
|Published||Content info||114 Pages
Delivery time: 2-3 business days
|Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2020 - 2027|
|Published: September 7, 2020||Content info: 114 Pages||
Neuralgia Treatment Market Growth & Trends
The global neuralgia treatment market size is expected to reach USD 2.8 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc. The rising geriatric population, increasing incidence of trigeminal neuralgia, and the growing prevalence of diabetes are the key factors driving the market. Neuralgia is a burning, stabbing, and severe pain due to a damaged or irritated nerve.
The chronic pain in the nerves can occur due to various factors such as infection, diabetes, aging, multiple sclerosis, or any similar disorders that damage the myelin sheath protecting certain nerves. Tumor compressing the trigeminal nerve can also cause the disorder. The prevalence of chronic pain in the trigeminal nerve increases with the aging population. According to the estimates published by the WHO, the geriatric population is anticipated to rise from 900.0 million in 2015 to 2.0 billion in 2050. The geriatric population is prone to many diseases such as diabetes and trigeminal neuralgia.
As per the American Association of Neuromuscular and Electrodiagnostic Medicine, the disorder usually affects the population aged 50 years or older. It also reported that women are more prone to trigeminal neuralgia than men. As per the study, The Patient's Journey Through Trigeminal Neuralgia published by the International Association for The Study of Pain (IASP), the incidence rate of the disorder in the general population is 3.4 to 5.9 per 100,000 population. It also reported that the incidence rate is comparatively higher in the geriatric population. Such factors are expected to boost market growth over the forecast period. Stereotactic radiosurgery and microvascular decompression are the two most common procedures being adopted to treat the disorder.
Neuralgia Treatment Market Report Highlights
On the basis of treatment, the surgery segment held the largest market share in 2019 owing to rising awareness regarding various treatment options and the high cost of surgeries
The surgery segment has been further sub-segmented into Radiofrequency Thermal Lesioning, Stereotactic Radiosurgery, Microvascular Decompression, and others
The ambulatory surgery center segment is anticipated to witness the fastest growth over the forecast period owing to the rising demand for a reduced hospital stay
In North America, the market held the largest revenue share in 2019 owing to the presence of key players in the region.